Literature DB >> 24113997

Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema.

Sachi Abe1, Teiko Yamamoto, Yoshiko Kashiwagi, Eriko Kirii, Sakiko Goto, Hidetoshi Yamashita.   

Abstract

PURPOSE: To report the findings of fine folds on the retina obtained by spectral-domain optical coherence tomography (OCT).
METHODS: A retrospective non-comparative case series; 26 eyes of diabetic macular edema (DME) patients who underwent vitrectomy were observed using three-dimensional (3D) images of OCT preoperatively and postoperatively. The specimens were investigated immunohistochemically.
RESULTS: Using only tomography, non-tractional vitreoretinal interfaces were observed in 15 eyes and tractional vitreoretinal interfaces in the other 11 eyes. Using 3D imaging, we observed fine folds in 11 eyes among 15 cases showing non-tractional interfaces. Based on these findings, the state of the vitreoretinal interface was classified into 3 patterns. Group 1, both tomography and 3D imaging showed smooth retinal surfaces. Group 2, tomography showed a smooth retinal surface, but 3D imaging showed fine folds on the retina. Group 3, both tomography and 3D imaging showed a tractional vitreoretinal interface with an obvious epiretinal membrane and/or taut posterior vitreous cortex. The fine folds in group 2 disappeared and macular edema improved after inner limiting membrane (ILM) peeling, and the CRT of groups 2 and 3 reduced significantly. The fine folds were confirmed to involve the ILM because type IV collagen expression was detected in the surgically obtained specimens.
CONCLUSION: We observed tangential fine folds of the ILM. These were detected by using only 3D imaging, and might be useful for investigating the optimal indication of vitrectomy for DME.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24113997     DOI: 10.1007/s10384-013-0275-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  30 in total

1.  Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

Authors:  S D Pendergast; T S Hassan; G A Williams; M S Cox; R R Margherio; P J Ferrone; B R Garretson; M T Trese
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

3.  Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.

Authors:  Teiko Yamamoto; Koichiro Hitani; Yukihiro Sato; Hidetoshi Yamashita; Shinobu Takeuchi
Journal:  Ophthalmologica       Date:  2005 Jul-Aug       Impact factor: 3.250

4.  Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.

Authors:  N Tachi; N Ogino
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

5.  Optical coherence tomographic patterns of diabetic macular edema.

Authors:  Brian Y Kim; Scott D Smith; Peter K Kaiser
Journal:  Am J Ophthalmol       Date:  2006-09       Impact factor: 5.258

6.  Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema.

Authors:  Kaoru Tamura; Toshiyuki Yokoyama; Nobuyuki Ebihara; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2012-03-23       Impact factor: 2.447

7.  Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide.

Authors:  Akiko Higuchi; Nahoko Ogata; Nobuo Jo; Mitsumasa Wada; Miyo Matsumura
Journal:  Jpn J Ophthalmol       Date:  2006-12-18       Impact factor: 2.447

8.  Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema.

Authors:  Tarek Alasil; Pearse A Keane; Jared F Updike; Laurie Dustin; Yanling Ouyang; Alexander C Walsh; Srinivas R Sadda
Journal:  Ophthalmology       Date:  2010-06-18       Impact factor: 12.079

9.  Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema.

Authors:  Erika Shimizu; Hideharu Funatsu; Hidetoshi Yamashita; Tetsuji Yamashita; Sadao Hori
Journal:  Jpn J Ophthalmol       Date:  2002 Jan-Feb       Impact factor: 2.447

10.  Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.

Authors:  Roy W Beck; Allison R Edwards; Lloyd P Aiello; Neil M Bressler; Frederick Ferris; Adam R Glassman; Elizabeth Hartnett; Michael S Ip; Judy E Kim; Craig Kollman
Journal:  Arch Ophthalmol       Date:  2009-03
View more
  5 in total

1.  Retinal findings in a patient of French ancestry with CABP4-related retinal disease.

Authors:  Vasily Mikhaïlovitch Smirnov; Christina Zeitz; Nagasamy Soumittra; Isabelle Audo; Sabine Defoort-Dhellemmes
Journal:  Doc Ophthalmol       Date:  2018-03-10       Impact factor: 2.379

2.  Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Reiji Yokota; Makoto Inoue; Yuji Itoh; Tosho Rii; Kazunari Hirota; Akito Hirakata
Journal:  Jpn J Ophthalmol       Date:  2015-07-23       Impact factor: 2.447

Review 3.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

4.  Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

Review 5.  The Vitreomacular Interface in Diabetic Retinopathy.

Authors:  Daniel Agarwal; Rachel Gelman; Claudia Prospero Ponce; William Stevenson; John B Christoforidis
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.